Prostate-specific antigen testing and opportunistic prostate cancer screening — informed consent

This is a comprehensive and well-researched project on the uptake and access of prostate cancer screening.¹ The authors correctly characterise the transition into a ‘post-trial world’ as the trend of prostate screening research is moving away from prostate-specific antigen (PSA) testing. However, at the time of writing the PSA test remains the primary screening …